Clinical trial
Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease
NCT05797207 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease
- Lead sponsor
- Istanbul Medipol University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 10, 2023
- Completion date
- December 31, 2024
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colonoscopy, inflammatory bowel diseases, microbiota